FDA Brief

Warning letters Drugs

FDA warning letter to

Chameleon Beverage Co. Inc. dba Chameleon Sanitizer Corporation

High riskIssued Sep 24, 2021Posted Nov 23, 2021Division of Pharmaceutical Quality Operations IV

FDA warned Chameleon Sanitizer Corporation that its hand sanitizer was made under insanitary conditions and violated manufacturing and misbranding rules.

What happened

FDA inspected the drug manufacturing facility from March 29 to April 2, 2021. It found hand sanitizer made under insanitary conditions, including filling from an open tote with a manual pump in an unlit area without contamination controls. FDA also cited failures in current good manufacturing practice (CGMP) quality oversight and cleaning, and said ALKEMI Hand Sanitizer Gel in 33.8 oz containers was misbranded because the bottle resembled a drinking water bottle.

What FDA found

  1. Hand sanitizer was prepared, packed, or held under insanitary conditions, including bulk product left open to the environment and manual pump filling without contamination controls.

    FD&C Act section 501(a)(2)(A), 21 U.S.C. 351(a)(2)(A)
  2. The quality control unit did not ensure CGMP compliance or meet specifications, including by not testing incoming components for identity, not verifying supplier certificates of analysis, and not setting finished-product specifications or doing release testing.

    21 CFR 211.22
  3. The firm lacked adequate written cleaning and maintenance procedures and records for equipment, including the manual pump used to fill hand sanitizer.

    21 CFR 211.67(b)
  4. The firm did not validate cleaning for a filling line shared with bottled drinking water, so cross-contamination controls were inadequate.

    21 CFR 211.67(b)
  5. ALKEMI Hand Sanitizer Gel in 33.8 oz bottles was misbranded because the clear, colorless product in a bottle resembling a drinking water bottle could mislead consumers.

    FD&C Act section 502(i)(1), 21 U.S.C. 352(i)(1)
  6. Hand sanitizer drug products were adulterated because the firm’s methods, facilities, and controls did not conform to CGMP.

    FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)

What FDA wants

FDA asks the company to respond in writing within 15 working days with what it has done to correct the violations and prevent recurrence, including quality-unit remediation, test methods and specifications, and a cleaning cross-contamination assessment and corrective action plan.

Who should pay attention

  • brands that buy hand sanitizer from contract manufacturers
  • companies sharing filling lines between drugs and food or beverage products
  • retailers and distributors selling hand sanitizer in drink-like containers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. CNC Noodle Corporation

    FDA warned CNC Noodle Corporation that its Hayward, California noodle plant had insanitary conditions, no pathogen or allergen controls, and mislabeled products.

    High risk
  2. ABC Food Corp

    ABC Food Corp's ready-to-eat rice noodles and tofu were made without required hazard analysis and preventive controls.

    High risk
  3. Rama Food Manufacture Corp.

    FDA warns Rama Food Manufacture after inspections found insanitary conditions and preventive-control failures at its California ready-to-eat rice noodle plants.

    High risk
  4. Lewis Sausage Company Inc.

    FDA found Salmonella and Listeria in contract-made pet food from Lewis Sausage and says its pathogen controls are inadequate.

    High risk